Chai
Structure prediction and de novo binder design aimed at drug programs.
Full Chai record →Head to head
Chai vs Xaira Therapeutics
Chai (Chai Discovery) and Xaira Therapeutics (Xaira Therapeutics) both sit in Science & Bio. Chai shipped more tracked changes in the last 30 days (8 vs 7). Every value below comes from the latest crawl of the vendors' own pages.
| Attribute | Chai Chai Discovery | Xaira Therapeutics Xaira Therapeutics |
|---|---|---|
| Segment | Science & Bio | Science & Bio |
| Version | Chai-1 | Xaira Platform |
| Entry cost | Pricing is not publicly listed (enterprise/licensing) | Pricing is not publicly disclosed (Enterprise/Drug Discovery Platform) |
| Pricing tiers | — | — |
| Model stack | Chai · Chai biological models · Chai-1 · Chai-2 | Proprietary · X-Atlas/Pisces · X-Automate · X-Cell · X-Design · X-Patient · X-Scientist |
| Context window | — | — |
| Public API | ||
| Routes models | ||
| Changes / 30d | 8 | 7 |
| Origin | United States | United States |
| Capabilities | De novo binders, Complex prediction, Antibody design, Web tool, drug discovery, molecule design, antibody discovery, molecular design | Generative protein design, Perturbation atlases, Wet-lab loop, predictive AI models, agentic AI models, virtual cells, drug discovery, AI models for drug discovery |
Xaira Therapeutics
Foundation-model-driven pipeline built on generative protein design and perturbation data.
Full Xaira Therapeutics record →